FY2025 · period end Dec '25 · from the 10-K filed Feb 3, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $2.82B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0001628280-26-031287 | Mar 31, 2026 | May 6, 2026 | May 6, 2026 20:16 UTC | EDGAR |
| 8-K | 0001628280-26-030561 | May 5, 2026 | May 5, 2026 | May 5, 2026 20:16 UTC | EDGAR |
| 8-K | 0000765880-26-000002 | Apr 30, 2026 | May 4, 2026 | May 4, 2026 20:30 UTC | EDGAR |
| 8-K | 0001104659-26-033312 | Mar 23, 2026 | Mar 23, 2026 | Mar 23, 2026 20:13 UTC | EDGAR |
| 8-K | 0001104659-26-020982 | Feb 27, 2026 | Feb 27, 2026 | Feb 27, 2026 12:15 UTC | EDGAR |
| 10-K | 0001628280-26-005044 | Dec 31, 2025 | Feb 3, 2026 | Feb 3, 2026 21:31 UTC | EDGAR |
| 8-K | 0001628280-26-004623 | Feb 2, 2026 | Feb 2, 2026 | Feb 2, 2026 21:18 UTC | EDGAR |
| 10-Q | 0001628280-25-046273 | Sep 30, 2025 | Oct 24, 2025 | Oct 24, 2025 20:16 UTC | EDGAR |
Direct links to SEC EDGAR. DOC has additional filings available on the SEC site.
6 numbers HEALTHPEAK PROPERTIES, INC. later changed — same XBRL tag, both filings linked.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·3 months to Dec 2019
Major restatementwas$40.3M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q2 2015
Major restatementwas$151.2M
Revised down in a 10-K.
Revenue from Contract with Customer, Excluding Assessed Tax·FY 2019
Major restatementwas$728M
Revised down in a 10-K. Any P/S built on the original was 404.4% too low.
Revenue from Contract with Customer, Excluding Assessed Tax·FY 2018
Major restatementwas$544.8M
Revised down in a 10-K. Any P/S built on the original was 277.7% too low.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q3 2016
Major restatementwas$153.9M
Revised down in a 10-K.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q1 2016
Major restatementwas$173.7M
Revised down in a 10-K.
DOC is not the only one.
See every restatement we've found across the market — or get an alert the next time DOC revises a number.
Restatements are detected by comparing every vintage of a fact across all of HEALTHPEAK PROPERTIES, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows DOC's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling HEALTHPEAK PROPERTIES, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on DOC yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on DOC and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $2.18B |
| $2.06B |
| $1.90B |
| Gross Profit | — | $1.63B | $1.28B | $1.20B | $1.12B |
|---|
| Operating Income | — | — | — | — | — |
|---|
| Net Income | $0.07B | $0.24B | $0.31B | $0.50B | $0.51B |
|---|
| EPS (Diluted) | $0.10 | $0.36 | $0.56 | $0.92 | $0.93 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $20.34B | $19.94B | $15.70B | $15.77B | $15.26B |
| Total Liabilities | $12.03B | $10.88B | $8.77B | $8.48B | $8.11B |
| Stockholders' Equity | $8.14B | $9.06B | $6.88B | $7.18B | $7.06B |
| Cash & Equivalents | $0.47B | $0.12B | $0.17B | $0.13B | $0.16B |
| Total Debt | $9.98B | $8.86B | $6.93B | $6.54B | $6.22B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.25B | $1.07B | $0.96B | $0.90B | $0.80B |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | — | 60.2% | 58.6% | 58.1% | 59.2% |
| Operating Margin | 1.9% | 2.9% | 2.3% | 2.5% | 2.3% |
| Net Margin | 0.1% | 0.4% | 0.6% | 1.0% | 1.1% |
| Return on Equity | 0.8% | 3.1% | 4.4% | 7.0% | 7.0% |
| Return on Assets | 0.4% | 1.4% | 1.9% | 3.2% | 3.2% |
| Debt / Equity | 1.23× | 0.98× | 1.01× | 0.91× | 0.88× |
